Author: Cheryl Stratos

“There are today 242 companies plus partners developing 273 drugs targeting melanoma in development.” Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients remains below 20%. There are today…